Background  	Background  	 FW	B-NP
Plasma  	Plasma  	 FW	I-NP
membrane  	membrane  	 FW	I-NP
microparticles  	microparticles  	 FW	I-NP
( 	( 	 -LRB-	O
MP 	MP 	 NNP	B-NP
)  	)  	 -RRB-	O
of  	of  	 IN	O
endothelial  	endothelial  	 JJ	B-NP
origin  	origin  	 NNS	I-NP
have  	have  	 VBP	O
been  	been  	 VBN	O
identified  	identified  	 VBN	O
in  	in  	 IN	O
normal  	normal  	 JJ	B-NP
human  	human  	 JJ	I-NP
blood  	blood  	 NN	I-NP
[  	[  	 -LRB-	O
1  	1  	 CD	O
2  	2  	 CD	O
3  	3  	 CD	O
]  	]  	 -RRB-	O
and  	and  	 CC	O
increased  	increased  	 JJ	O
counts  	counts  	 NNS	O
of  	of  	 IN	O
MP  	MP  	 NNP	B-NP
carrying  	carrying  	 VBG	O
endothelial  	endothelial  	 JJ	B-NP
antigens  	antigens  	 NN	I-NP
were  	were  	 VBD	O
documented  	documented  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
blood  	blood  	 NN	O
of  	of  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
lupus  	lupus  	 JJ	B-NP
anticoagulant  	anticoagulant  	 NNS	I-NP
[  	[  	 -LRB-	O
1  	1  	 LS	O
]  	]  	 -RRB-	O
,  	,  	 ,	O
acute  	acute  	 JJ	B-NP
coronary  	coronary  	 JJ	I-NP
syndrome  	syndrome  	 NN	I-NP
[  	[  	 -LRB-	O
4  	4  	 LS	O
]  	]  	 -RRB-	O
,  	,  	 ,	O
thrombotic  	thrombotic  	 FW	B-NP
thrombocytopenic  	thrombocytopenic  	 FW	I-NP
purpura  	purpura  	 FW	I-NP
[  	[  	 -LRB-	O
5  	5  	 LS	O
]  	]  	 -RRB-	O
or  	or  	 CC	O
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
exacerbated  	exacerbated  	 JJ	O
multiple  	multiple  	 JJ	O
sclerosis  	sclerosis  	 NNS	O
[  	[  	 -LRB-	O
6  	6  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Similarly  	Similarly  	 RB	O
to  	to  	 TO	O
blood  	blood  	 NN	B-NP
platelets 	platelets 	 NN	I-NP
,  	,  	 ,	O
endothelial  	endothelial  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
release  	release  	 VBP	O
MP  	MP  	 NNP	B-NP
which  	which  	 WDT	O
express  	express  	 VBP	O
phosphatidylserine  	phosphatidylserine  	 NNS	B-NP
( 	( 	 -LRB-	O
PS 	PS 	 NNP	B-NP
)  	)  	 -RRB-	O
on  	on  	 IN	O
their  	their  	 PRP$	O
surface 	surface 	 NN	O
.  	.  	 .	O
PS-exposing  	PS-exposing  	 NNP	B-NP
MP  	MP  	 NNP	I-NP
in  	in  	 IN	O
blood  	blood  	 NN	O
appear  	appear  	 VBP	O
to  	to  	 TO	O
act  	act  	 VB	O
as  	as  	 IN	O
the  	the  	 DT	O
catalytic  	catalytic  	 JJ	B-NP
surface  	surface  	 NN	I-NP
for  	for  	 IN	O
assembly  	assembly  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
prothrombinase  	prothrombinase  	 JJ	B-NP
complex  	complex  	 NN	I-NP
[  	[  	 -LRB-	O
7  	7  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Although  	Although  	 IN	O
circulating  	circulating  	 VBG	B-NP
MP  	MP  	 NNP	I-NP
of  	of  	 IN	O
various  	various  	 JJ	O
cellular  	cellular  	 JJ	B-NP
origin  	origin  	 NN	I-NP
in  	in  	 IN	O
patient  	patient  	 NN	O
with  	with  	 IN	O
sepsis  	sepsis  	 NN	O
were  	were  	 VBD	O
reported  	reported  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
procoagulant  	procoagulant  	 VBN	O
through  	through  	 IN	O
multiple  	multiple  	 JJ	O
mechanisms  	mechanisms  	 NNS	O
[  	[  	 -LRB-	O
8  	8  	 CD	O
9  	9  	 CD	O
]  	]  	 -RRB-	O
,  	,  	 ,	O
in  	in  	 IN	O
healthy  	healthy  	 JJ	O
individuals  	individuals  	 NNS	O
they  	they  	 PRP	O
may  	may  	 MD	O
have  	have  	 VB	O
an  	an  	 DT	O
anticoagulant  	anticoagulant  	 JJ	B-NP
function  	function  	 NN	I-NP
by  	by  	 IN	O
promoting  	promoting  	 VBG	O
the  	the  	 DT	O
generation  	generation  	 NN	O
of  	of  	 IN	O
low  	low  	 JJ	O
amounts  	amounts  	 NNS	O
of  	of  	 IN	O
thrombin  	thrombin  	 NN	B-NP
that  	that  	 IN	O
activate  	activate  	 JJ	B-NP
protein  	protein  	 NN	I-NP
C  	C  	 NNP	I-NP
[  	[  	 -LRB-	O
2  	2  	 LS	O
]  	]  	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
process  	process  	 NN	O
of  	of  	 IN	O
membrane  	membrane  	 JJ	B-NP
vesiculation  	vesiculation  	 NN	I-NP
and  	and  	 CC	O
MP-release  	MP-release  	 JJ	B-NP
in  	in  	 IN	O
platelets  	platelets  	 NN	B-NP
has  	has  	 VBZ	O
been  	been  	 VBN	O
shown  	shown  	 VBN	O
to  	to  	 TO	O
require  	require  	 VB	O
a  	a  	 DT	O
calpain-dependent  	calpain-dependent  	 JJ	B-NP
dissociation  	dissociation  	 NN	I-NP
of  	of  	 IN	O
membrane  	membrane  	 JJ	O
proteins  	proteins  	 NNS	O
from  	from  	 IN	O
the  	the  	 DT	O
submembrane  	submembrane  	 JJ	B-NP
cytoskeleton  	cytoskeleton  	 NN	I-NP
and  	and  	 CC	O
most  	most  	 RBS	O
likely  	likely  	 JJ	O
involves  	involves  	 NNS	O
intracellular  	intracellular  	 VBP	O
signaling  	signaling  	 VBG	O
by  	by  	 IN	O
platelet  	platelet  	 JJ	B-NP
protein  	protein  	 NN	I-NP
kinases  	kinases  	 NNS	I-NP
[  	[  	 -LRB-	O
10  	10  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Besides  	Besides  	 IN	O
platelets  	platelets  	 JJ	B-NP
stimulated  	stimulated  	 NN	I-NP
by  	by  	 IN	O
various  	various  	 JJ	O
agonists  	agonists  	 JJ	O
such  	such  	 JJ	O
as  	as  	 IN	O
thrombin  	thrombin  	 NN	B-NP
with  	with  	 IN	O
collagen  	collagen  	 NN	B-NP
or  	or  	 CC	O
the  	the  	 DT	O
complement  	complement  	 JJ	O
complex  	complex  	 JJ	O
C5b-9  	C5b-9  	 NNP	O
[  	[  	 -LRB-	O
7  	7  	 CD	O
11  	11  	 CD	O
]  	]  	 -RRB-	O
,  	,  	 ,	O
a  	a  	 DT	O
release  	release  	 NN	O
of  	of  	 IN	O
PS-containing  	PS-containing  	 JJ	B-NP
membrane  	membrane  	 JJ	I-NP
MP  	MP  	 NNP	I-NP
was  	was  	 VBD	O
demonstrated  	demonstrated  	 VBN	O
in  	in  	 IN	O
other  	other  	 JJ	O
cell  	cell  	 NN	O
types  	types  	 NNS	O
such  	such  	 JJ	O
as  	as  	 IN	O
endotoxin-stimulated  	endotoxin-stimulated  	 JJ	B-NP
monocytes  	monocytes  	 NNS	I-NP
[  	[  	 -LRB-	O
12  	12  	 CD	O
]  	]  	 -RRB-	O
,  	,  	 ,	O
polymorphonuclear  	polymorphonuclear  	 NNS	B-NP
leucocytes  	leucocytes  	 VBP	I-NP
stimulated  	stimulated  	 VBN	O
with  	with  	 IN	O
the  	the  	 DT	O
chemotactic  	chemotactic  	 FW	B-NP
peptide  	peptide  	 FW	I-NP
FMLP  	FMLP  	 FW	I-NP
[  	[  	 -LRB-	O
13  	13  	 CD	O
]  	]  	 -RRB-	O
or  	or  	 CC	O
apoptotic  	apoptotic  	 JJ	B-NP
T-lymphocytes  	T-lymphocytes  	 NN	I-NP
[  	[  	 -LRB-	O
14  	14  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
normal  	normal  	 JJ	B-NP
restriction  	restriction  	 NN	I-NP
of  	of  	 IN	I-NP
PS  	PS  	 NNP	I-NP
to  	to  	 TO	O
the  	the  	 DT	O
inner  	inner  	 JJ	O
surface  	surface  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
plasma  	plasma  	 JJ	B-NP
membrane  	membrane  	 NN	I-NP
becomes  	becomes  	 VBZ	O
perturbed  	perturbed  	 VBN	O
in  	in  	 IN	O
apoptotic  	apoptotic  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
[  	[  	 -LRB-	O
15  	15  	 CD	O
16  	16  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
When  	When  	 WRB	O
exposed 	exposed 	 VBN	O
,  	,  	 ,	O
PS  	PS  	 NNP	B-NP
is  	is  	 VBZ	O
a  	a  	 DT	O
determinant  	determinant  	 NN	B-NP
for  	for  	 IN	I-NP
phagocyte  	phagocyte  	 JJ	I-NP
recognition  	recognition  	 NN	I-NP
of  	of  	 IN	O
cells  	cells  	 NNS	O
to  	to  	 TO	O
be  	be  	 VB	O
cleared 	cleared 	 VBN	O
.  	.  	 .	O
Plasma  	Plasma  	 JJ	B-NP
membrane  	membrane  	 JJ	I-NP
blebbing  	blebbing  	 NN	I-NP
and  	and  	 CC	O
MP-release  	MP-release  	 NNS	B-NP
are  	are  	 VBP	O
generally  	generally  	 RB	O
accepted  	accepted  	 VBN	O
as  	as  	 IN	O
typical  	typical  	 JJ	O
signs  	signs  	 NNS	O
of  	of  	 IN	O
cell  	cell  	 NN	B-NP
apoptosis  	apoptosis  	 NNS	I-NP
[  	[  	 -LRB-	O
17  	17  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
In  	In  	 IN	O
addition  	addition  	 NN	O
to  	to  	 TO	O
a  	a  	 DT	O
possible  	possible  	 JJ	O
pathophysiological  	pathophysiological  	 JJ	B-NP
role  	role  	 NN	I-NP
of  	of  	 IN	I-NP
circulating  	circulating  	 VBG	I-NP
MP 	MP 	 NNP	I-NP
,  	,  	 ,	O
analysis  	analysis  	 NN	O
of  	of  	 IN	O
MP  	MP  	 NNP	B-NP
derived  	derived  	 VBD	O
from  	from  	 IN	O
endothelial  	endothelial  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
a  	a  	 DT	O
valuable  	valuable  	 JJ	O
diagnostic  	diagnostic  	 JJ	B-NP
marker  	marker  	 NN	I-NP
of  	of  	 IN	I-NP
vessel  	vessel  	 JJ	I-NP
wall  	wall  	 NN	I-NP
injury 	injury 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
phospholipid-binding  	phospholipid-binding  	 JJ	B-NP
protein  	protein  	 NN	I-NP
annexin  	annexin  	 VBD	O
V  	V  	 NNP	O
has  	has  	 VBZ	O
a  	a  	 DT	O
high  	high  	 JJ	O
affinity  	affinity  	 NN	B-NP
for  	for  	 IN	I-NP
PS  	PS  	 NNP	I-NP
[  	[  	 -LRB-	O
18  	18  	 CD	O
]  	]  	 -RRB-	O
and  	and  	 CC	O
is  	is  	 VBZ	O
utilized  	utilized  	 VBN	O
in  	in  	 IN	O
MP  	MP  	 NNP	B-NP
detection  	detection  	 NN	I-NP
in  	in  	 IN	O
blood  	blood  	 NN	O
and  	and  	 CC	O
in  	in  	 IN	O
cell  	cell  	 NN	B-NP
supernatants  	supernatants  	 NNS	I-NP
[  	[  	 -LRB-	O
1  	1  	 LS	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Since  	Since  	 IN	O
very  	very  	 RB	O
little  	little  	 RB	O
is  	is  	 VBZ	O
known  	known  	 VBN	O
about  	about  	 IN	O
the  	the  	 DT	O
mechanism  	mechanism  	 NN	O
of  	of  	 IN	O
MP-release  	MP-release  	 JJ	B-NP
from  	from  	 IN	O
endothelial  	endothelial  	 JJ	B-NP
cell 	cell 	 NN	I-NP
,  	,  	 ,	O
it  	it  	 PRP	O
is  	is  	 VBZ	O
difficult  	difficult  	 JJ	O
to  	to  	 TO	O
judge  	judge  	 VB	O
the  	the  	 DT	O
type  	type  	 NN	O
and  	and  	 CC	O
extent  	extent  	 NN	O
of  	of  	 IN	O
endothelial  	endothelial  	 JJ	B-NP
injury  	injury  	 NN	I-NP
represented  	represented  	 VBD	O
by  	by  	 IN	O
increased  	increased  	 JJ	O
plasma  	plasma  	 NN	B-NP
counts  	counts  	 NNS	I-NP
of  	of  	 IN	I-NP
endothelial  	endothelial  	 JJ	I-NP
MP 	MP 	 NNP	I-NP
.  	.  	 .	O
We  	We  	 PRP	O
used  	used  	 VBD	O
flow  	flow  	 NN	B-NP
cytometry  	cytometry  	 NN	I-NP
to  	to  	 TO	O
study  	study  	 VB	O
the  	the  	 DT	O
release  	release  	 NN	O
of  	of  	 IN	O
annexin  	annexin  	 FW	B-NP
V-binding  	V-binding  	 FW	O
membrane  	membrane  	 FW	B-NP
microparticles  	microparticles  	 FW	I-NP
from  	from  	 FW	O
cultured  	cultured  	 FW	O
human  	human  	 FW	B-NP
umbilical  	umbilical  	 FW	I-NP
vein  	vein  	 FW	I-NP
endothelial  	endothelial  	 FW	I-NP
cell  	cell  	 FW	I-NP
( 	( 	 -LRB-	O
HUVEC 	HUVEC 	 NNP	B-NP
)  	)  	 -RRB-	O
stimulated  	stimulated  	 VBN	O
by  	by  	 IN	O
various  	various  	 JJ	O
agonists 	agonists 	 NN	B-NP
.  	.  	 .	O
We  	We  	 PRP	O
further  	further  	 RB	O
focused  	focused  	 VBN	O
our  	our  	 PRP$	O
study  	study  	 NN	O
on  	on  	 IN	O
MP-release  	MP-release  	 JJ	B-NP
from  	from  	 IN	O
HUVEC  	HUVEC  	 NNP	B-NP
after  	after  	 IN	O
proapoptotic  	proapoptotic  	 JJ	B-NP
stimulation  	stimulation  	 NN	I-NP
with  	with  	 IN	O
the  	the  	 DT	O
topoisomerase  	topoisomerase  	 NN	B-NP
I  	I  	 PRP	I-NP
inhibitor  	inhibitor  	 VBP	I-NP
camptothecin  	camptothecin  	 NNS	I-NP
( 	( 	 -LRB-	O
CPT 	CPT 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Since  	Since  	 IN	O
CPT  	CPT  	 NNP	B-NP
analogues  	analogues  	 VBD	I-NP
become  	become  	 VBN	O
one  	one  	 CD	O
of  	of  	 IN	O
the  	the  	 DT	O
most  	most  	 RBS	O
promising  	promising  	 JJ	O
new  	new  	 JJ	O
classes  	classes  	 NNS	O
of  	of  	 IN	O
antineoplastic  	antineoplastic  	 JJ	B-NP
agents  	agents  	 NNS	I-NP
introduced  	introduced  	 VBN	O
into  	into  	 IN	O
the  	the  	 DT	O
clinic  	clinic  	 NN	O
in  	in  	 IN	O
recent  	recent  	 JJ	O
years  	years  	 NNS	O
[  	[  	 -LRB-	O
19  	19  	 CD	O
]  	]  	 -RRB-	O
,  	,  	 ,	O
activity  	activity  	 NN	O
of  	of  	 IN	O
camptothecin  	camptothecin  	 NN	B-NP
on  	on  	 IN	O
endothelial  	endothelial  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
of  	of  	 IN	O
great  	great  	 JJ	O
interest 	interest 	 NN	O
.  	.  	 .	O
Results  	Results  	 NNS	O
With  	With  	 IN	O
the  	the  	 DT	O
exception  	exception  	 NN	O
of  	of  	 IN	O
high  	high  	 JJ	O
concentration  	concentration  	 NN	B-NP
of  	of  	 IN	I-NP
ionophore  	ionophore  	 CD	I-NP
A23187 	A23187 	 CD	O
,  	,  	 ,	O
rapid  	rapid  	 JJ	B-NP
stimulation  	stimulation  	 NN	I-NP
of  	of  	 IN	I-NP
HUVEC  	HUVEC  	 NNP	I-NP
with  	with  	 IN	O
various  	various  	 JJ	O
agonists  	agonists  	 NN	B-NP
did  	did  	 VBD	O
not  	not  	 RB	O
result  	result  	 VB	O
in  	in  	 IN	O
a  	a  	 DT	O
release  	release  	 NN	O
of  	of  	 IN	O
annexin  	annexin  	 FW	B-NP
V-binding  	V-binding  	 FW	O
microparticles  	microparticles  	 FW	B-NP
Flow  	Flow  	 FW	I-NP
cytometry  	cytometry  	 FW	I-NP
analysis  	analysis  	 NN	I-NP
of  	of  	 IN	O
HUVEC  	HUVEC  	 NNP	B-NP
culture  	culture  	 NN	I-NP
supernatant  	supernatant  	 VBZ	O
demonstrated  	demonstrated  	 VBN	O
that  	that  	 IN	O
a  	a  	 DT	O
30  	30  	 CD	O
min  	min  	 JJ	B-NP
treatment  	treatment  	 NN	I-NP
with  	with  	 IN	O
10  	10  	 CD	O
μM  	μM  	 JJ	B-NP
ionophore  	ionophore  	 NNS	I-NP
A23187  	A23187  	 VBP	O
caused  	caused  	 VBN	O
the  	the  	 DT	O
release  	release  	 NN	O
of  	of  	 IN	O
low  	low  	 JJ	O
counts  	counts  	 NNS	O
of  	of  	 IN	O
annexin  	annexin  	 JJ	B-NP
V-binding  	V-binding  	 JJ	I-NP
MP  	MP  	 NNP	I-NP
( 	( 	 -LRB-	O
Fig.  	Fig.  	 NNP	O
1A 	1A 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Similar  	Similar  	 JJ	B-NP
short-time  	short-time  	 JJ	I-NP
activation  	activation  	 NN	I-NP
of  	of  	 IN	I-NP
HUVEC  	HUVEC  	 NNP	I-NP
with  	with  	 IN	O
phorbol  	phorbol  	 FW	B-NP
myristate  	myristate  	 FW	I-NP
acetate  	acetate  	 FW	I-NP
( 	( 	 -LRB-	O
PMA 	PMA 	 NNP	B-NP
)  	)  	 -RRB-	O
( 	( 	 -LRB-	O
1  	1  	 CD	O
μg 	μg 	 CD	B-NP
/ 	/ 	 CD	I-NP
mL 	mL 	 NN	I-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
human  	human  	 JJ	O
thrombin  	thrombin  	 FW	B-NP
receptor  	receptor  	 FW	I-NP
activating  	activating  	 FW	I-NP
peptide  	peptide  	 FW	I-NP
( 	( 	 -LRB-	O
TRAP 	TRAP 	 NNP	B-NP
)  	)  	 -RRB-	O
1-50  	1-50  	 FW	O
μmol 	μmol 	 FW	B-NP
/ 	/ 	 FW	I-NP
L 	L 	 NNP	I-NP
,  	,  	 ,	O
human  	human  	 JJ	O
thrombin  	thrombin  	 NNS	B-NP
( 	( 	 -LRB-	O
THR 	THR 	 NNP	B-NP
)  	)  	 -RRB-	O
0.1-10  	0.1-10  	 NNP	O
NIH  	NIH  	 NNP	B-NP
Unit 	Unit 	 NNP	O
/ 	/ 	 NNP	O
mL 	mL 	 NNP	O
,  	,  	 ,	O
human  	human  	 JJ	O
tissue  	tissue  	 NN	B-NP
plasminogen  	plasminogen  	 NN	I-NP
activator  	activator  	 NNS	I-NP
( 	( 	 -LRB-	O
TPA 	TPA 	 NNP	B-NP
)  	)  	 -RRB-	O
3.5  	3.5  	 CD	O
kU 	kU 	 JJ	O
/ 	/ 	 NNP	O
mL  	mL  	 NNP	O
or  	or  	 CC	O
human  	human  	 JJ	O
angiotensin  	angiotensin  	 JJ	B-NP
II  	II  	 NNP	I-NP
( 	( 	 -LRB-	O
AGTII 	AGTII 	 NNP	B-NP
)  	)  	 -RRB-	O
1  	1  	 CD	O
μmol 	μmol 	 CD	B-NP
/ 	/ 	 CD	I-NP
L  	L  	 NNP	I-NP
did  	did  	 VBD	O
not  	not  	 RB	O
cause  	cause  	 VB	O
any  	any  	 DT	O
significant  	significant  	 JJ	O
increase  	increase  	 NN	O
in  	in  	 IN	O
MP-release  	MP-release  	 NNP	B-NP
( 	( 	 -LRB-	O
Fig.  	Fig.  	 NNP	O
1A 	1A 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
All  	All  	 DT	O
of  	of  	 IN	O
the  	the  	 DT	O
agonists  	agonists  	 NN	B-NP
applied  	applied  	 VBD	O
induced  	induced  	 VBN	O
morphological  	morphological  	 JJ	B-NP
changes  	changes  	 NNS	I-NP
in  	in  	 IN	O
HUVEC  	HUVEC  	 NNP	B-NP
seen  	seen  	 VBN	O
by  	by  	 IN	O
phase  	phase  	 NN	O
contrast  	contrast  	 NN	O
light  	light  	 NN	O
microscopy 	microscopy 	 NN	O
,  	,  	 ,	O
which  	which  	 WDT	O
confirmed  	confirmed  	 VBD	O
the  	the  	 DT	O
cellular  	cellular  	 JJ	B-NP
activation  	activation  	 NNS	I-NP
( 	( 	 -LRB-	O
not  	not  	 RB	O
shown 	shown 	 VBN	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Proapoptotic 	Proapoptotic 	 NNP	B-NP
,  	,  	 ,	O
but  	but  	 CC	O
not  	not  	 RB	O
proinflammatory 	proinflammatory 	 JJ	O
,  	,  	 ,	O
stimulation  	stimulation  	 VBD	O
induced  	induced  	 VBN	O
a  	a  	 DT	O
release  	release  	 NN	O
of  	of  	 IN	O
annexin  	annexin  	 JJ	B-NP
V-binding  	V-binding  	 JJ	I-NP
microparticles  	microparticles  	 NN	I-NP
from  	from  	 IN	O
HUVEC  	HUVEC  	 NNP	B-NP
MP  	MP  	 NNP	I-NP
count  	count  	 NN	I-NP
increased  	increased  	 VBD	O
overnight  	overnight  	 JJ	O
in  	in  	 IN	O
the  	the  	 DT	O
media  	media  	 NNS	O
of  	of  	 IN	O
unstimulated  	unstimulated  	 JJ	B-NP
cell  	cell  	 NN	I-NP
culture 	culture 	 NN	I-NP
,  	,  	 ,	O
but  	but  	 CC	O
this  	this  	 DT	O
was  	was  	 VBD	O
not  	not  	 RB	O
enhanced  	enhanced  	 VBN	O
by  	by  	 IN	O
TNFα  	TNFα  	 NNP	B-NP
( 	( 	 -LRB-	O
1000  	1000  	 CD	O
U 	U 	 NNP	O
/  	/  	 NNP	O
mL 	mL 	 NNP	O
)  	)  	 -RRB-	O
or  	or  	 CC	O
by  	by  	 IN	O
LPS  	LPS  	 NNP	B-NP
( 	( 	 -LRB-	O
10  	10  	 CD	O
μg 	μg 	 CD	B-NP
/ 	/ 	 CD	I-NP
mL 	mL 	 NN	I-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
when  	when  	 WRB	O
cells  	cells  	 NNS	O
were  	were  	 VBD	O
activated  	activated  	 VBN	O
with  	with  	 IN	O
TNFα  	TNFα  	 JJ	O
in  	in  	 IN	O
the  	the  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
cycloheximide  	cycloheximide  	 NNS	B-NP
( 	( 	 -LRB-	O
50  	50  	 CD	O
μg 	μg 	 CD	B-NP
/ 	/ 	 CD	I-NP
mL 	mL 	 NN	I-NP
)  	)  	 -RRB-	O
to  	to  	 TO	O
promote  	promote  	 VB	O
apoptosis  	apoptosis  	 NNS	B-NP
[  	[  	 -LRB-	O
20  	20  	 CD	O
]  	]  	 -RRB-	O
,  	,  	 ,	O
a  	a  	 DT	O
dramatic  	dramatic  	 JJ	O
increase  	increase  	 NN	O
in  	in  	 IN	O
MP  	MP  	 NNP	B-NP
count  	count  	 NN	I-NP
was  	was  	 VBD	O
observed 	observed 	 VBN	O
,  	,  	 ,	O
as  	as  	 RB	O
compared  	compared  	 VBN	O
to  	to  	 TO	O
TNFα  	TNFα  	 JJ	O
or  	or  	 CC	O
cycloheximide  	cycloheximide  	 JJ	B-NP
treatment  	treatment  	 NN	I-NP
alone  	alone  	 RB	O
( 	( 	 -LRB-	O
Fig.  	Fig.  	 NNP	O
1B 	1B 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Similarly 	Similarly 	 RB	O
,  	,  	 ,	O
induction  	induction  	 VBG	O
of  	of  	 IN	O
apoptosis  	apoptosis  	 NN	B-NP
with  	with  	 IN	O
5  	5  	 CD	O
μM  	μM  	 JJ	B-NP
CPT 	CPT 	 NNP	I-NP
,  	,  	 ,	O
a  	a  	 DT	O
topoisomerase  	topoisomerase  	 NN	B-NP
I  	I  	 PRP	I-NP
inhibitor  	inhibitor  	 VBP	O
[  	[  	 -LRB-	O
19  	19  	 CD	O
]  	]  	 -RRB-	O
,  	,  	 ,	O
led  	led  	 VBN	O
to  	to  	 TO	O
a  	a  	 DT	O
release  	release  	 NN	O
of  	of  	 IN	O
annexin  	annexin  	 JJ	B-NP
V-binding  	V-binding  	 JJ	I-NP
MP  	MP  	 NNP	I-NP
which  	which  	 WDT	O
was  	was  	 VBD	O
prevented  	prevented  	 VBN	O
by  	by  	 IN	O
ZVAD 	ZVAD 	 NNP	B-NP
.  	.  	 .	O
ZVAD  	ZVAD  	 NNP	B-NP
also  	also  	 RB	O
inhibited  	inhibited  	 VBD	O
a  	a  	 DT	O
release  	release  	 NN	O
of  	of  	 IN	O
MP  	MP  	 NNP	B-NP
from  	from  	 IN	O
unstimulated  	unstimulated  	 JJ	B-NP
cells 	cells 	 NNS	I-NP
,  	,  	 ,	O
which  	which  	 WDT	O
probably  	probably  	 RB	O
represents  	represents  	 VBZ	O
spontaneous  	spontaneous  	 JJ	B-NP
apoptosis  	apoptosis  	 NN	I-NP
of  	of  	 IN	O
cultured  	cultured  	 JJ	O
HUVEC  	HUVEC  	 NNP	B-NP
( 	( 	 -LRB-	O
Fig.  	Fig.  	 NNP	O
1B 	1B 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
MP-release  	MP-release  	 NNP	B-NP
did  	did  	 VBD	O
not  	not  	 RB	O
correlate  	correlate  	 VBN	O
with  	with  	 IN	O
the  	the  	 DT	O
level  	level  	 NN	O
of  	of  	 IN	O
cell  	cell  	 NN	B-NP
apoptosis  	apoptosis  	 NN	I-NP
in  	in  	 IN	O
HUVEC  	HUVEC  	 NNP	B-NP
stimulated  	stimulated  	 NN	I-NP
with  	with  	 IN	O
camptothecin  	camptothecin  	 JJ	B-NP
Phase  	Phase  	 NN	I-NP
contrast  	contrast  	 NN	I-NP
microscopy  	microscopy  	 NNS	I-NP
showed  	showed  	 VBD	O
that  	that  	 IN	O
HUVEC  	HUVEC  	 NNP	B-NP
culture  	culture  	 NN	I-NP
treated  	treated  	 VBN	O
for  	for  	 IN	O
24  	24  	 CD	O
hrs  	hrs  	 NN	B-NP
with  	with  	 IN	O
5  	5  	 CD	O
μM  	μM  	 JJ	B-NP
CPT  	CPT  	 NNP	I-NP
( 	( 	 -LRB-	O
Fig.  	Fig.  	 NNP	O
2C 	2C 	 NNP	O
)  	)  	 -RRB-	O
lost  	lost  	 VBD	O
confluence  	confluence  	 VBN	O
with  	with  	 IN	O
about  	about  	 IN	O
30-40 	30-40 	 CD	O
%  	%  	 NN	O
cells  	cells  	 NNS	O
remaining  	remaining  	 VBG	B-NP
adherent 	adherent 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
level  	level  	 NN	O
of  	of  	 IN	O
apoptosis  	apoptosis  	 NN	B-NP
of  	of  	 IN	I-NP
adherent  	adherent  	 JJ	I-NP
cells  	cells  	 NNS	I-NP
was  	was  	 VBD	O
assessed  	assessed  	 VBN	O
by  	by  	 IN	O
using  	using  	 VBG	O
TUNEL  	TUNEL  	 NNP	B-NP
and  	and  	 CC	O
annexin  	annexin  	 FW	B-NP
V-FITC 	V-FITC 	 FW	I-NP
/  	/  	 FW	O
propidium  	propidium  	 FW	B-NP
iodide  	iodide  	 FW	I-NP
assays  	assays  	 FW	I-NP
( 	( 	 -LRB-	O
Fig  	Fig  	 NNP	O
3 	3 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Approximately  	Approximately  	 RB	O
one  	one  	 CD	O
third  	third  	 JJ	O
of  	of  	 IN	O
the  	the  	 DT	O
remaining  	remaining  	 JJ	O
adherent  	adherent  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
showed  	showed  	 VBD	O
annexin  	annexin  	 JJ	B-NP
V-binding  	V-binding  	 NN	I-NP
( 	( 	 -LRB-	O
Fig.  	Fig.  	 NNP	O
3B 	3B 	 NNP	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
DNA-fragmentation  	DNA-fragmentation  	 NNP	B-NP
( 	( 	 -LRB-	O
TUNEL-positivity 	TUNEL-positivity 	 NNP	B-NP
)  	)  	 -RRB-	O
( 	( 	 -LRB-	O
Fig.  	Fig.  	 NNP	O
3C 	3C 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Interestingly 	Interestingly 	 RB	O
,  	,  	 ,	O
a  	a  	 DT	O
ten  	ten  	 JJ	O
times  	times  	 NNS	O
lower  	lower  	 JJR	O
concentration  	concentration  	 NN	B-NP
of  	of  	 IN	I-NP
CPT  	CPT  	 NNP	I-NP
( 	( 	 -LRB-	O
500  	500  	 CD	O
nM 	nM 	 NN	B-NP
)  	)  	 -RRB-	O
also  	also  	 RB	O
induced  	induced  	 VBN	O
significant  	significant  	 JJ	O
MP-release  	MP-release  	 NN	B-NP
after  	after  	 IN	O
only  	only  	 RB	O
4  	4  	 CD	O
hrs  	hrs  	 NN	B-NP
of  	of  	 IN	O
treatment  	treatment  	 NN	O
( 	( 	 -LRB-	O
Fig.  	Fig.  	 NNP	O
3A 	3A 	 NNP	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
after  	after  	 IN	O
24  	24  	 CD	O
hrs 	hrs 	 NN	B-NP
,  	,  	 ,	O
500  	500  	 CD	O
nM  	nM  	 JJ	B-NP
camptothecin  	camptothecin  	 NNS	I-NP
induced  	induced  	 VBP	I-NP
MP-release  	MP-release  	 JJ	I-NP
comparable  	comparable  	 JJ	O
to  	to  	 TO	O
5  	5  	 CD	O
μM  	μM  	 JJ	B-NP
CPT  	CPT  	 NNP	I-NP
treatment 	treatment 	 NN	I-NP
,  	,  	 ,	O
but  	but  	 CC	O
without  	without  	 IN	O
any  	any  	 DT	O
significant  	significant  	 JJ	O
increase  	increase  	 NN	O
in  	in  	 IN	O
annexin  	annexin  	 JJ	B-NP
V-binding  	V-binding  	 JJ	I-NP
to  	to  	 TO	O
the  	the  	 DT	O
cells  	cells  	 NNS	O
or  	or  	 CC	O
DNA-fragmentation  	DNA-fragmentation  	 NNP	B-NP
( 	( 	 -LRB-	O
Fig.  	Fig.  	 NNP	O
3B 	3B 	 NNP	O
, 	, 	 ,	O
3C 	3C 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
cell  	cell  	 NN	O
culture  	culture  	 NN	O
was  	was  	 VBD	O
still  	still  	 RB	O
confluent  	confluent  	 JJ	O
( 	( 	 -LRB-	O
Fig.  	Fig.  	 NNP	O
2B 	2B 	 NNP	O
)  	)  	 -RRB-	O
with  	with  	 IN	O
about  	about  	 IN	O
20-30 	20-30 	 CD	O
%  	%  	 NN	O
lower  	lower  	 JJR	O
cell  	cell  	 NN	O
density  	density  	 VBZ	O
as  	as  	 RB	O
compared  	compared  	 VBN	O
with  	with  	 IN	O
0.5 	0.5 	 CD	O
%  	%  	 NN	O
DMSO  	DMSO  	 NNP	B-NP
treated  	treated  	 VBD	I-NP
HUVEC  	HUVEC  	 NNP	I-NP
( 	( 	 -LRB-	O
Fig.  	Fig.  	 NNP	O
2A 	2A 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
This  	This  	 DT	O
result  	result  	 NN	O
indicates  	indicates  	 VBZ	O
that  	that  	 IN	O
MP-release  	MP-release  	 NNP	B-NP
is  	is  	 VBZ	O
not  	not  	 RB	O
related  	related  	 VBN	O
to  	to  	 TO	O
cell  	cell  	 NN	B-NP
desquamation 	desquamation 	 NN	I-NP
.  	.  	 .	O
To  	To  	 TO	O
investigate  	investigate  	 VB	O
whether  	whether  	 IN	O
maturation  	maturation  	 NN	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
cell  	cell  	 NN	O
culture  	culture  	 NN	O
influences  	influences  	 VBZ	O
the  	the  	 DT	O
degree  	degree  	 NN	O
of  	of  	 IN	O
MP-release  	MP-release  	 JJ	B-NP
from  	from  	 IN	O
HUVEC  	HUVEC  	 NNP	B-NP
in  	in  	 IN	O
response  	response  	 NN	O
to  	to  	 TO	O
CPT 	CPT 	 NNP	B-NP
,  	,  	 ,	O
we  	we  	 PRP	O
compared  	compared  	 VBD	O
MP-release  	MP-release  	 JJ	B-NP
from  	from  	 IN	O
subconfluent  	subconfluent  	 JJ	B-NP
HUVEC  	HUVEC  	 NNP	I-NP
( 	( 	 -LRB-	O
50 	50 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
confluence 	confluence 	 CD	B-NP
)  	)  	 -RRB-	O
at  	at  	 IN	O
24  	24  	 CD	O
hrs  	hrs  	 NN	B-NP
in  	in  	 IN	O
culture 	culture 	 NN	O
,  	,  	 ,	O
HUVEC  	HUVEC  	 NNP	B-NP
reaching  	reaching  	 VBG	I-NP
confluence  	confluence  	 NN	I-NP
at  	at  	 IN	O
48  	48  	 CD	O
hrs  	hrs  	 NN	B-NP
in  	in  	 IN	O
culture  	culture  	 NN	O
and  	and  	 CC	O
overgrown  	overgrown  	 JJ	O
HUVEC  	HUVEC  	 NN	B-NP
at  	at  	 IN	O
72  	72  	 CD	O
hrs  	hrs  	 NN	B-NP
in  	in  	 IN	O
culture 	culture 	 NN	O
.  	.  	 .	O
Our  	Our  	 PRP$	O
results  	results  	 NNS	O
showed  	showed  	 VBD	O
that  	that  	 DT	O
MP-release  	MP-release  	 JJ	B-NP
in  	in  	 IN	O
response  	response  	 NN	O
to  	to  	 TO	O
CPT  	CPT  	 NNP	B-NP
declined  	declined  	 VBD	O
with  	with  	 IN	O
culture  	culture  	 NN	B-NP
maturation 	maturation 	 NN	I-NP
.  	.  	 .	O
There  	There  	 EX	O
was  	was  	 VBD	O
also  	also  	 RB	O
a  	a  	 DT	O
change  	change  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
sensitivity  	sensitivity  	 NN	O
of  	of  	 IN	O
overgrown  	overgrown  	 JJ	O
HUVEC  	HUVEC  	 NN	B-NP
to  	to  	 TO	O
CPT  	CPT  	 NNP	B-NP
treatment  	treatment  	 NN	I-NP
in  	in  	 IN	O
confluent  	confluent  	 CD	O
72  	72  	 CD	O
hrs  	hrs  	 CD	B-NP
old  	old  	 JJ	O
culture  	culture  	 NN	O
resulting  	resulting  	 VBG	O
in  	in  	 IN	O
the  	the  	 DT	O
higher  	higher  	 JJR	O
concentration  	concentration  	 NN	B-NP
of  	of  	 IN	I-NP
CPT  	CPT  	 NNP	I-NP
( 	( 	 -LRB-	O
5  	5  	 CD	O
μM 	μM 	 NN	B-NP
)  	)  	 -RRB-	O
releasing  	releasing  	 VBG	O
higher  	higher  	 JJR	O
levels  	levels  	 NNS	O
of  	of  	 IN	O
MP  	MP  	 NNP	B-NP
( 	( 	 -LRB-	O
Fig.  	Fig.  	 CD	O
4 	4 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
In  	In  	 IN	O
growing  	growing  	 VBG	O
culture  	culture  	 NN	O
at  	at  	 IN	O
24  	24  	 CD	O
hrs 	hrs 	 NN	B-NP
,  	,  	 ,	O
500  	500  	 CD	O
nM  	nM  	 JJ	B-NP
CPT  	CPT  	 NNP	I-NP
caused  	caused  	 VBD	O
even  	even  	 RB	O
higher  	higher  	 JJR	O
MP-release  	MP-release  	 NN	B-NP
than  	than  	 IN	O
5  	5  	 CD	O
μM  	μM  	 JJ	B-NP
CPT 	CPT 	 NNP	I-NP
.  	.  	 .	O
In  	In  	 IN	O
confluent  	confluent  	 JJ	O
HUVEC  	HUVEC  	 NNP	B-NP
48  	48  	 CD	O
hrs  	hrs  	 CD	B-NP
old 	old 	 JJ	O
,  	,  	 ,	O
the  	the  	 DT	O
MP-release  	MP-release  	 JJ	B-NP
induced  	induced  	 NN	I-NP
by  	by  	 IN	O
500  	500  	 CD	O
nM  	nM  	 JJ	O
and  	and  	 CC	O
5  	5  	 CD	O
μM  	μM  	 JJ	B-NP
CPT  	CPT  	 NNP	I-NP
was  	was  	 VBD	O
not  	not  	 RB	O
significantly  	significantly  	 RB	O
different  	different  	 JJ	O
( 	( 	 -LRB-	O
Fig.  	Fig.  	 CD	O
4 	4 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Endothelial  	Endothelial  	 JJ	B-NP
antigens  	antigens  	 JJ	I-NP
CD  	CD  	 NN	O
105  	105  	 CD	O
and  	and  	 CC	O
CD  	CD  	 NNP	O
59  	59  	 CD	O
were  	were  	 VBD	O
both  	both  	 DT	O
expressed  	expressed  	 VBN	O
on  	on  	 IN	O
living  	living  	 VBG	B-NP
cells 	cells 	 NNS	I-NP
,  	,  	 ,	O
apoptotic  	apoptotic  	 JJ	B-NP
bodies  	bodies  	 NNS	I-NP
and  	and  	 CC	O
other  	other  	 JJ	O
cell  	cell  	 NN	O
fragments  	fragments  	 NNS	O
in  	in  	 IN	O
CPT  	CPT  	 NNP	B-NP
treated  	treated  	 VBD	I-NP
HUVEC  	HUVEC  	 NNP	I-NP
culture  	culture  	 NN	I-NP
but  	but  	 CC	O
CD  	CD  	 NNP	O
105  	105  	 CD	O
was  	was  	 VBD	O
absent  	absent  	 VBN	O
on  	on  	 IN	O
50 	50 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
annexin  	annexin  	 JJ	B-NP
V-binding  	V-binding  	 JJ	I-NP
membrane  	membrane  	 NNS	I-NP
microparticles  	microparticles  	 VBP	O
Using  	Using  	 VBG	B-NP
flow  	flow  	 NN	I-NP
cytometry 	cytometry 	 NN	I-NP
,  	,  	 ,	O
in  	in  	 IN	O
SSC  	SSC  	 NNP	B-NP
vs.  	vs.  	 FW	O
FSC  	FSC  	 FW	B-NP
plot  	plot  	 FW	O
we  	we  	 FW	O
gated  	gated  	 FW	O
homogeneous  	homogeneous  	 FW	B-NP
population  	population  	 NN	I-NP
of  	of  	 IN	O
single  	single  	 JJ	O
living  	living  	 NN	O
cells  	cells  	 NNS	O
( 	( 	 -LRB-	O
G1  	G1  	 NNP	O
on  	on  	 IN	O
Fig.  	Fig.  	 CD	O
5A 	5A 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
which  	which  	 WDT	O
appeared  	appeared  	 VBD	O
negative  	negative  	 JJ	O
in  	in  	 IN	O
propidium  	propidium  	 FW	B-NP
iodide  	iodide  	 FW	I-NP
staining  	staining  	 FW	O
( 	( 	 -LRB-	O
Fig.  	Fig.  	 NNP	O
5B 	5B 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Living  	Living  	 VBG	B-NP
cells  	cells  	 NNS	I-NP
from  	from  	 IN	O
control  	control  	 NN	B-NP
cultures  	cultures  	 NNS	I-NP
as  	as  	 IN	O
well  	well  	 RB	O
as  	as  	 RB	O
from  	from  	 IN	O
cultures  	cultures  	 NNS	O
treated  	treated  	 VBN	O
with  	with  	 IN	O
CPT  	CPT  	 NNP	B-NP
were  	were  	 VBD	O
strongly  	strongly  	 RB	O
positive  	positive  	 JJ	O
for  	for  	 IN	O
both  	both  	 DT	O
antigens  	antigens  	 JJ	O
CD  	CD  	 NN	O
105  	105  	 CD	O
and  	and  	 CC	O
CD  	CD  	 NNP	O
59  	59  	 CD	O
( 	( 	 -LRB-	O
Fig.  	Fig.  	 NNP	O
5C 	5C 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Expression  	Expression  	 NN	O
of  	of  	 IN	O
CD59  	CD59  	 CD	B-NP
on  	on  	 IN	O
endothelial  	endothelial  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
was  	was  	 VBD	O
not  	not  	 RB	O
influenced  	influenced  	 VBN	O
by  	by  	 IN	O
24  	24  	 CD	O
hrs  	hrs  	 JJ	B-NP
incubation  	incubation  	 NN	I-NP
with  	with  	 IN	O
500nM  	500nM  	 NNP	O
or  	or  	 CC	O
5μM  	5μM  	 NNP	B-NP
CPT  	CPT  	 NNP	I-NP
as  	as  	 RB	O
compared  	compared  	 VBN	O
with  	with  	 IN	O
control  	control  	 NN	B-NP
cells  	cells  	 NNS	I-NP
incubated  	incubated  	 VBN	O
with  	with  	 IN	O
0.5 	0.5 	 CD	O
%  	%  	 NN	O
DMSO 	DMSO 	 NNP	B-NP
.  	.  	 .	O
Expression  	Expression  	 NN	O
of  	of  	 IN	O
CD105  	CD105  	 NNP	B-NP
was  	was  	 VBD	O
only  	only  	 RB	O
slightly  	slightly  	 RB	O
decreased  	decreased  	 VBN	O
on  	on  	 IN	O
CPT  	CPT  	 NNP	B-NP
treated  	treated  	 VBD	O
cells 	cells 	 NNS	O
.  	.  	 .	O
Cell  	Cell  	 NN	O
fragments  	fragments  	 VBZ	O
>  	>  	 CD	O
4  	4  	 CD	O
μm  	μm  	 NN	B-NP
in  	in  	 IN	O
size  	size  	 NN	O
as  	as  	 IN	O
compared  	compared  	 VBN	O
with  	with  	 IN	O
standard  	standard  	 JJ	O
beads  	beads  	 NN	O
were  	were  	 VBD	O
gated  	gated  	 VBN	O
separately  	separately  	 RB	O
( 	( 	 -LRB-	O
G2  	G2  	 NNP	O
on  	on  	 IN	O
Fig.  	Fig.  	 CD	O
5A 	5A 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Larger  	Larger  	 JJR	O
cell  	cell  	 NN	O
fragments  	fragments  	 NNS	O
appeared  	appeared  	 VBD	O
positive  	positive  	 JJ	O
in  	in  	 IN	O
propidium  	propidium  	 FW	B-NP
iodide  	iodide  	 FW	I-NP
staining  	staining  	 FW	O
( 	( 	 -LRB-	O
Fig.  	Fig.  	 NNP	O
5B 	5B 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
All  	All  	 DT	O
analyzed  	analyzed  	 JJ	O
cell  	cell  	 NN	O
fragments  	fragments  	 NNS	O
were  	were  	 VBD	O
positive  	positive  	 JJ	O
for  	for  	 IN	O
CD59  	CD59  	 NNP	B-NP
and  	and  	 CC	O
also  	also  	 RB	O
expressed  	expressed  	 VBD	O
CD  	CD  	 NNP	O
105  	105  	 CD	O
( 	( 	 -LRB-	O
Fig.  	Fig.  	 NNP	O
5D 	5D 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Comparison  	Comparison  	 NN	O
of  	of  	 IN	O
areas  	areas  	 NNS	O
under  	under  	 IN	O
the  	the  	 DT	O
different  	different  	 JJ	O
peaks  	peaks  	 NNS	O
on  	on  	 IN	O
the  	the  	 DT	O
histogram  	histogram  	 NN	O
( 	( 	 -LRB-	O
Fig.  	Fig.  	 NNP	O
5C 	5C 	 NNP	O
, 	, 	 ,	O
5D 	5D 	 CD	O
)  	)  	 -RRB-	O
indicates  	indicates  	 VBZ	O
that  	that  	 IN	O
the  	the  	 DT	O
portion  	portion  	 NN	O
of  	of  	 IN	O
cell  	cell  	 NN	O
fragments  	fragments  	 VBZ	O
corresponding  	corresponding  	 JJ	O
to  	to  	 TO	O
apoptotic  	apoptotic  	 VB	O
bodies  	bodies  	 NNS	O
and  	and  	 CC	O
necrotic  	necrotic  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
was  	was  	 VBD	O
significantly  	significantly  	 RB	O
higher  	higher  	 JJR	O
in  	in  	 IN	O
culture  	culture  	 NN	O
treated  	treated  	 VBN	O
with  	with  	 IN	O
5  	5  	 CD	O
μM  	μM  	 JJ	B-NP
CPT  	CPT  	 NNP	I-NP
as  	as  	 RB	O
compared  	compared  	 VBN	O
to  	to  	 TO	O
culture  	culture  	 VB	O
treated  	treated  	 VBN	O
with  	with  	 IN	O
500  	500  	 CD	O
nM  	nM  	 JJ	B-NP
CPT  	CPT  	 NNP	I-NP
or  	or  	 CC	O
with  	with  	 IN	O
0.5 	0.5 	 CD	O
%  	%  	 NN	O
DMSO  	DMSO  	 NNP	B-NP
alone 	alone 	 RB	O
.  	.  	 .	O
In  	In  	 IN	O
a  	a  	 DT	O
separate  	separate  	 JJ	O
protocol  	protocol  	 NN	O
we  	we  	 PRP	O
analyzed  	analyzed  	 VBD	O
the  	the  	 DT	O
expression  	expression  	 NN	O
of  	of  	 IN	O
CD  	CD  	 NNP	O
59  	59  	 CD	O
and  	and  	 CC	O
CD  	CD  	 NNP	O
105  	105  	 CD	O
on  	on  	 IN	O
membrane  	membrane  	 JJ	B-NP
MP 	MP 	 NNP	I-NP
.  	.  	 .	O
Comparison  	Comparison  	 NN	O
of  	of  	 IN	O
FSC  	FSC  	 NNP	B-NP
values  	values  	 NNS	O
of  	of  	 IN	O
standard  	standard  	 JJ	O
beads  	beads  	 NN	O
and  	and  	 CC	O
analyzed  	analyzed  	 VBD	B-NP
MP  	MP  	 NNP	I-NP
showed  	showed  	 VBD	O
that  	that  	 IN	O
95 	95 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
annexin  	annexin  	 JJ	B-NP
V-binding  	V-binding  	 JJ	I-NP
MP  	MP  	 NNP	I-NP
released  	released  	 VBD	O
from  	from  	 IN	O
HUVEC  	HUVEC  	 NNP	B-NP
were  	were  	 VBD	O
